Testing effectiveness (Phase 2)Looking for participantsNCT04570423
What this trial is testing
Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
Who this might be right for
Solid TumorsLymphoma
Spectrum Pharmaceuticals, Inc 40